Elis: Disclosure Of Trading In Own Shares Occured From December 4 To December 5, 2025

2025-12-09 02:02:43

(MENAFN- GlobeNewsWire - Nasdaq) Disclosure of trading in own shares occurred
from December 4 to December 5, 2025

Puteaux, December 9, 2025

In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from December 4 to December 5, 2025 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025 and announced on March 6, 2025:

Aggregated presentation:

Issuer name	Issuer code (LEI)	Transaction date	ISIN Code	Daily total Volume (in number of shares)	Daily weighted average price of shares acquired (in euros)	Platform (MIC Code)
ELIS SA	969500UX71LCE8MAY492	12/04/2025	FR0012435121	28,000	23,8988	CEUX
ELIS SA	969500UX71LCE8MAY492	12/04/2025	FR0012435121	62,000	23,9046	XPAR
ELIS SA	969500UX71LCE8MAY492	12/04/2025	FR0012435121	6,000	23,8909	AQEU
ELIS SA	969500UX71LCE8MAY492	12/04/2025	FR0012435121	4,000	23,9014	TQEX
ELIS SA	969500UX71LCE8MAY492	12/05/2025	FR0012435121	41,000	23,7541	XPAR
ELIS SA	969500UX71LCE8MAY492	12/05/2025	FR0012435121	9,000	23,7635	CEUX
	Total	150,000	23.8533

The purpose of the own shares purchase operations is (i) to cover maturing performance share plans and to allocate free shares to employees as part of the contribution to the Elis for All 2025 international employee shareholding plan, and (ii) to be cancelled in accordance with the 26th resolution of the Combined General Meeting of May 22, 2025.

Contacts

Nicolas Buron
Director of Investor Relations, Financing & Treasury
Phone: + 33 (0)1 75 49 98 30 - ...

Charline Lefaucheux
Investor Relations
Phone: + 33 (0)1 75 49 98 15 - ...

Attachment

Elis - Disclosure of trading in own shares occured from December 4 to December 5, 2025

MENAFN09122025004107003653ID1110455749

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.